Trinity Care Solutions Recalls Tobramycin Syringes Due to Sterility Concerns
Trinity Care Solutions is recalling 14 units of Tobramycin 300 mg/7.5 mL syringes in Florida due to quality control concerns regarding sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in a parenteral product, which poses a significant risk of infection and potential serious injury.
Plain-English summary
Trinity Care Solutions, operating as Franck's Lab Inc, is recalling 14 units of Tobramycin 300 mg/7.5 mL Syringes (for Neb). The affected product is identified by Rx # 28503 and has an expiration date of 02/27/14. The recall is limited to distribution in Florida.
The recall was initiated due to concerns associated with quality control procedures observed during a recent FDA inspection. Specifically, there is a lack of assurance of sterility for the sterile products compounded by the pharmacy within their expiry period. The agency has classified this recall as Class II.
Consumers and healthcare providers in Florida who possess this specific product should stop using it and contact the recalling firm or their healthcare provider for instructions on return or disposal.
The recalled product
- Product
- Tobramycin 300 mg/7.5 mL Syringe (for Neb), Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 28503, Discard After 02/27/14
- Manufacturer
- Franck's Lab Inc dba Trinity Care Solutions
- Affected units
- 14
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Rx # 28503
- Exp 02/27/14
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 30 recalled by Franck's Lab Inc dba Trinity Care Solutions under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 30 products in this recall →Related recalls
Same manufacturer · Franck's Lab Inc dba Trinity Care Solutions
See all →- SevereTrinity Care Solutions Recalls ANA Kit Due to Sterility Concerns
FDA (Drugs) · 2014-07-30
- SevereTrinity Care Solutions Recalls Compounded Cubicin Due to Sterility Concerns
FDA (Drugs) · 2014-07-30
- SevereTrinity Care Solutions Recalls Desferal Sterile Compounds Due to Sterility Concerns
FDA (Drugs) · 2014-07-30
- SevereTrinity Care Solutions Recalls Compounded Cubicin Due to Sterility Concerns
FDA (Drugs) · 2014-07-30
- SevereTrinity Care Solutions Recalls Unasyn Due to Sterility Concerns
FDA (Drugs) · 2014-07-30
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereNora Apothecary Recalls Tobramycin Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
- SevereLiberty Drug Recalls Tobramycin Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
- SevereTobramycin Solution Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2014-11-12
- HighMitomycin Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2022-11-09
- SevereMoses Lake Pharmacy Recalls Trimix Injectable Solution Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04